1. Home
  2. CNTN vs SANG Comparison

CNTN vs SANG Comparison

Compare CNTN & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canton Strategic Holdings Inc. Common Stock

CNTN

Canton Strategic Holdings Inc. Common Stock

BUY

Current Price

$1.75

Market Cap

178.5M

Sector

Health Care

ML Signal

BUY

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

HOLD

Current Price

$4.82

Market Cap

160.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTN
SANG
Founded
2017
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
178.5M
160.1M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
CNTN
SANG
Price
$1.75
$4.82
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $5.50
AVG Volume (30 Days)
★ 729.5K
297.2K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 88.10
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.23
Revenue Next Year
N/A
$0.96
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$3.40
52 Week High
$5.27
$5.42

Technical Indicators

Market Signals
Indicator
CNTN
SANG
Relative Strength Index (RSI) 31.57 64.93
Support Level N/A $4.64
Resistance Level $3.80 $4.76
Average True Range (ATR) 0.13 0.09
MACD -0.07 -0.01
Stochastic Oscillator 3.49 23.08

Price Performance

Historical Comparison
CNTN
SANG

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic location USA and Other countries. Key revenue is generated from USA.

Share on Social Networks: